MedPath

tility of a new imaging test to diagnose mold (fungus) infection in children with cancer who have reduced immunity

Not Applicable
Conditions
Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: C920- Acute myeloblastic leukemia
Registration Number
CTRI/2021/03/032396
Lead Sponsor
AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children (less than 18 years) with hematological malignancy and FN (either post chemotherapy or after hematopoietic stem cell transplantation), who shows any abnormality on CECT scan; will be recruited after obtaining informed written consent.

Exclusion Criteria

1.Solid malignancies after chemotherapy having neutropenia

2.Other causes of neutropenia

3.Patients who refused to give consent

4.Patients with impaired renal function (Serum Creatinine > 1.3 mg%)

5.Patients with a normal CECT scan

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath